Achieve Life Sciences ACHV 深 滬
交易中 09-10 10:12:23 美东时间
3.09
-0.030
-0.96%
華盛通- 最 高3.14
- 今 開3.10
- 成交量 9.30万股
- 最 低 3.0811
- 昨 收 3.12
- 總市值 1.58亿
- 52周最高 5.31
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 1.84
- 委 比 -96.72%
- 總股本 5110.50万
- 歷史最高 970.00
- 量 比 0.90
- 振 幅 1.89%
- 歷史最低 1.84
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Achieve Life Sciences, Inc. announced that its CEO, Rick Stewart, will participate in two upcoming conferences: the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, and the Lake Street 9th Annual Best Ideas Growth Conference (BIG9) on September 11, 2025. Both events will take place in New York, NY. Achieve is focused on developing cytisinicline, a plant-based alkaloid for smoking cessation, and has submitted a New Dr...
09-02 12:30
HC Wainwright & Co. Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $12
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $12.
08-21 19:10
Achieve Life Sciences Advances Cytisinicline Development
Achieve Life Sciences ( ($ACHV) ) has released its Q2 earnings. Here is a break...
08-08 13:26
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
Achieve Life Sciences Inc. announced its second-quarter 2025 financial results, highlighting the submission of a New Drug Application (NDA) for cytisinicline to the FDA, a strategic partnership with Omnicom for commercial launch, and a $49.3 million public offering to support further development. The company also met FDA long-term safety requirements and published Phase 3 trial results in the *Journal of the American Medical Association (JAMA) In...
08-07 11:30
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
Achieve Life Sciences, a late-stage specialty pharmaceutical company, announced its participation in the BTIG Virtual Biotechnology Conference on July 29-30, 2025. CEO Rick Stewart will engage in a fireside chat on July 29 at 3:20 pm EDT. The company is focused on developing cytisinicline, a plant-based alkaloid, as a treatment for nicotine dependence and smoking cessation. Cytisinicline has received Breakthrough Therapy designation from the FDA ...
07-29 12:30
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025
Achieve Life Sciences announced it will report its Q2 2025 financial results and provide an update on cytisinicline development on August 7, 2025. The company submitted a New Drug Application to the FDA in June 2025 for cytisinicline, a plant-based alkaloid for nicotine dependence treatment. Over 29 million adults in the U.S. smoke combustible cigarettes, and 17 million use e-cigarettes. No FDA-approved treatments exist for vaping cessation. Cyti...
07-24 12:30
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
Achieve Life Sciences, Inc. completed an underwritten public offering of 15 million shares of common stock and warrants, raising $45 million. Proceeds will fund the advancement of cytisinicline, a potential treatment for nicotine dependence, toward FDA approval. The company is focused on addressing smoking and vaping cessation, with cytisinicline already granted Breakthrough Therapy designation. The offering was led by Citizens Capital Markets an...
06-30 23:52
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers NanoVibronix (NASDAQ:NAOV) shares increased by 45.2% to $1.25 during T...
06-27 05:05
Achieve Life Sciences shares are trading lower after the company announced a proposed underwritten public offering.
Achieve Life Sciences shares are trading lower after the company announced a pr...
06-27 04:05
